Jun 28, 2024, 00:56
Mark Lewis: This is the football/oncology crossover I’m here for
Mark Lewis shared a post on X:
“This is the football/oncology crossover I’m here for, Chiara Cremolini!
I agree KEYNOTE-177 v CheckMate 8HW is fraught with the pitfalls of cross-trial comparison (FWIW, I still favor pembro alone unless I really need a quick response making anti-CTLA4 more worthwhile).”
Source: Mark Lewis/X
Mark Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent and young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 28, 2024, 10:49
Dec 28, 2024, 10:39
Dec 28, 2024, 10:35
Dec 28, 2024, 09:40
Dec 28, 2024, 09:25
Dec 28, 2024, 09:13